How effective Is Invokana?

Invokana (canagliflozin) is typically used with other diabetes meds, like metformin, to lower blood sugar.

• When used alone in studies, Invokana lowered HbA1C (a measure of blood sugar control over the past two to three months) by 0.77% to 1%, so it's a weak blood sugar lowering agent by itself. Roughly 45% to 62% of patients were able to get their HbA1C below 7%.
• Invokana is also used as an "adjunct" (added to) to metformin, which boosts blood sugar control even further.
• There's a combined pill that makes it easier. Invokamet contains both metformin and canagliflozin in one tablet, which may be more convenient.

Invokana is a sodium-glucose co-transporter 2 (SGLT2) inhibitor. The SGLT2 inhibitors block the kidney from reabsorbing sugar (glucose). In turn, you eliminate more glucose in your urine which lowers your blood sugar levels. Invokana is also associated with reductions in blood pressure and weight loss and comes as a tablet taken once daily by mouth.

In October 2018 the FDA cleared Invokana to lower the risk of major adverse cardiovascular (CV) events, including heart attack, stroke or death in patients with type 2 diabetes who have established CV disease.

• For patients with type 2 diabetes and established heart disease, the American Diabetes Association (ADA) recommends medication management with SGLT2 inhibitors that specifically have a proven cardiovascular benefit, such as canagliflozin (Invokana) or empagliflozin (Jardiance). Patients should have adequate kidney function for the chosen agent.
• Both agents have shown a reduction in heart failure and chronic kidney disease progression in cardiovascular outcomes trials.
• This new indication also applies to the fixed-dose combination products.

In September 2019, Janssen’s Invokana was also approved to reduce the risk of end-stage kidney disease (ESKD), worsening of kidney function, cardiovascular (CV) death, and hospitalization for heart failure in adults with type 2 diabetes (T2D) and diabetic kidney disease.

Related: Invokana FDA Approval History

This is not all the information you need to know about Invokana (canagliflozin) for safe and effective use and does not take the place of your doctor’s directions. Review the full product information and discuss this information and any questions you have with your doctor or other health care provider.

Related questions

• Can Januvia and Invokana be taken together?
• Does Invokana cause weight loss?
• What are the dangers / risks of Invokana?

Read next

See also:

Related medical questions

• Is it safe to take Invokana?
• Is Invokana the same as metformin?
• What is the safest diabetes medication?
• What foods should I eat or avoid for hypoglycemia?
• Can you have hypoglycemia without diabetes?
• What is the connection between the endocrine system and osteoporosis?
• Which type of insulin has the longest duration of action?
• Mounjaro vs Ozempic: Which is right for you?
• Zepbound Vs Mounjaro: Complete Comparison Guide for Weight Loss and Diabetes Treatment
• Ozempic Side Effects to Watch For
• Why am I not losing weight on Mounjaro?
• What are the long-term side effects of Ozempic?
• How long does metformin take to work?
• Mounjaro side effects you need to be aware of
• How long does it take for Ozempic to work?
• Wegovy vs Ozempic: Which is Right for You?
• When is the best time to take metformin?
• How many doses are in an Ozempic pen?
• What is A1C? Normal vs dangerous levels, and how to lower It
• Tirzepatide vs semaglutide: How do they compare?
• Do Ozempic, Wegovy, Mounjaro & Zepbound cause hair loss?
• What happens when you stop taking Ozempic?
• Can you switch between Ozempic and Mounjaro?
• Does Ozempic need to be refrigerated?
• Why does metformin cause diarrhea?
• Saxenda vs Ozempic: For Weight Loss?
• Will my insurance cover the cost of Ozempic?
• How does Mounjaro Work for Weight Loss?
• Can you get tirzepatide from a compounding pharmacy?
• Is Mounjaro covered by insurance or Medicare?

Drug information

• Invokana (257 reviews)
• Canagliflozin (265 reviews)

Related support groups

• Invokana (11 questions, 48 members)
• Canagliflozin (2 questions, 5 members)
• Diabetes, Type 2 (502 questions, 1,428 members)
• Cardiovascular Risk Reduction (100 questions, 28 members)
• Diabetic Kidney Disease (9 questions, 24 members)
• Diabetic Nephropathy (9 questions, 21 members)

Medical Disclaimer